Skip to main content

Nurse-Led Strategy Reduces Cardiovascular Risk Factors for People With HIV

Medically reviewed by Carmen Pope, BPharm. Last updated on March 11, 2024.

By Lori Solomon HealthDay Reporter

MONDAY, March 11, 2024 -- Nurse-led management can lower cardiovascular risk factors among individuals with HIV receiving antiretroviral therapy, according to a study published online March 5 in JAMA Network Open.

Christopher T. Longenecker, M.D., from University of Washington in Seattle, and colleagues assessed whether a multicomponent nurse-led strategy could improve systolic blood pressure (SBP) and non-high-density lipoprotein (HDL) cholesterol level in a diverse population of 297 people with HIV receiving antiretroviral therapy.

The researchers found that at 12 months, participants randomly assigned to the nurse intervention had a clinically significant 4.2-mm Hg lower SBP and 16.9-mg/dL lower non-HDL cholesterol level versus participants in the control arm. For women, there was a clinically meaningful but not statistically significant difference in SBP effect compared with men (four months: 11.8-mm Hg greater difference; eight months: 9.6 mm Hg; 12 months: 5.9 mm Hg).

"Findings of this trial suggest that nurse-led cardiovascular risk factor management in academic HIV clinics may lead to fewer cardiovascular events and should inform implementation of prevention programs for people with HIV," the authors write. "Future research should explore the most effective components, dose, and mediators of these effects."

Two authors disclosed ties to Gilead Sciences; one author disclosed ties to Theratechnologies.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Semaglutide Cuts Risk for Kidney Outcomes, Death in CKD With T2DM

FRIDAY, May 31, 2024 -- For patients with type 2 diabetes and chronic kidney disease, semaglutide reduces the risk for clinically important kidney outcomes and death from...

DNA Methylation-Based Epigenetic Age Mediates Link Between LE8 Score, CVD

WEDNESDAY, May 29, 2024 -- The associations between Life's Essential 8 (LE8) and cardiovascular health are mediated by DNA methylation-based epigenetic age, according to a study...

Voluntary Medical Male Circumcision May Reduce Risk for HIV Infection

TUESDAY, May 28, 2024 -- For men who have sex with men (MSM), voluntary medical male circumcision (VMMC) is associated with a reduced risk for HIV infection, according to a study...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.